Nurix Therapeutics, Inc. Quarterly Operating Lease, Liability in USD from Q1 2022 to Q4 2024

Taxonomy & unit: us-gaap: USD
Description: Present value of lessee's discounted obligation for lease payments from operating lease.
Summary: Nurix Therapeutics, Inc. quarterly Operating Lease, Liability history and growth rate from Q1 2022 to Q4 2024.
Nurix Therapeutics, Inc. Operating Lease, Liability for the quarter ending November 30, 2024 was $28.3M, a 7.55% decline year-over-year.

Operating Lease, Liability, Quarterly (USD)

Operating Lease, Liability, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q4 2024	$28.3M	-$2.31M	-7.55%	Nov 30, 2024	10-K	2025-01-28
Q4 2023	$30.6M	+$18.7M	+156%	Nov 30, 2023	10-K	2024-02-15
Q4 2022	$12M			Nov 30, 2022	10-K	2023-02-09
Q3 2022	$13.2M			Aug 31, 2022	10-Q	2022-10-06
Q2 2022	$14.5M			May 31, 2022	10-Q	2022-07-07
Q1 2022	$15.8M			Feb 28, 2022	10-Q	2022-04-08

* An asterisk sign (*) next to the value indicates that the value is likely invalid.